Feb 9, 2024
January 26, 2025
This week’s newsletter included:
- Life Sciences Day on the Hill Recap
- AdvaMed Appoints BioUtah CEO, Kelvyn Cullimore, as New Chair of its State Medtech Alliance
- Halia Therapeutics is Collaborating with Canary Speech to Leverage AI- Driven Speech Technology
- Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
- Clene Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial
- Eris Biotech Accepted to Y Combinator
- Legislative Recap
- New Resource Launched for Utah Entrepreneurs
- University Track from the 2023 Utah Life Sciences Summit
- ARUP Quarterly Webinar Series
- CMS Publishes Draft Local Coverage Determination for KidneyIntelX, kidneyintelX.dkd
Featured new member: Spire therapeutics
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
